xRead - September 2022

Wise et al.

Page 229

955. Fuiano N, Fusilli S, Incorvaia C. A role for measurement of nasal IgE antibodies in diagnosis of Alternaria-induced rhinitis in children. Allergol Immunopathol (Madr). 2012;40:71–74. [PubMed: 21641712] 956. Reisacher WR. Total and allergen-specific immunoglobulin E in the serum and nasal mucosa of a nonallergic population. Int Forum Allergy Rhinol. 2016;6:618–623. [PubMed: 26833576] 957. Rondon C, Blanca-Lopez N, Aranda A, et al. Local allergic rhinitis: allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen. J Allergy Clin Immunol. 2011;127:1069–1071. [PubMed: 21277626] 958. Kim JH, Yoon MG, Seo DH, et al. Detection of allergen specific antibodies from nasal secretion of allergic rhinitis patients. Allergy Asthma Immunol Res. 2016;8:329–337. [PubMed: 27126726] 959. Lee KS, Yu J, Shim D, et al. Local immune responses in children and adults with allergic and nonallergic rhinitis. PLoS One. 2016;11:e0156979. [PubMed: 27281182] 960. Sakaida H, Masuda S, Takeuchi K. Measurement of Japanese cedar pollen-specific IgE in nasal secretions. Allergol Int. 2014;63:467–473. [PubMed: 24957114] 961. Ota Y, Ikemiyagi Y, Sato T, et al. Measuring local immunoglobulin E in the inferior turbinate nasal mucosa in patients with allergic rhinitis. Allergol Int. 2016;65:396–399. [PubMed: 27516133] 962. Becker S, Rasp J, Eder K, Berghaus A, Kramer MF, Groger M. Non-allergic rhinitis with eosinophilia syndrome is not associated with local production of specific IgE in nasal mucosa. Eur Arch Otorhinolaryngol. 2016;273:1469–1475. [PubMed: 26342925] 963. Reisacher WR. Detecting local immunoglobulin E from mucosal brush biopsy of the inferior turbinates using microarray analysis. Int Forum Allergy Rhinol. 2013;3:399–403. [PubMed: 23136039] 964. Reisacher WR. Mucosal brush biopsy testing of the inferior turbinate to detect local, antigen specific immunoglobulin E. Int Forum Allergy Rhinol. 2012;2:69–74. [PubMed: 22311844] 965. Sensi LG, Piacentini GL, Nobile E, et al. Changes in nasal specific IgE to mites after periods of allergen exposure-avoidance: a comparison with serum levels. Clin Exp Allergy. 1994;24:377– 382. [PubMed: 8039025] 966. Hoffmann HJ, Knol EF, Ferrer M, et al. Pros and cons of clinical basophil testing (BAT). Curr Allergy Asthma Rep. 2016;16:56. [PubMed: 27411319] 967. Sanz ML, Sanchez G, Gamboa PM, et al. Allergen-induced basophil activation: CD63 cell expression detected by flow cytometry in patients allergic to Dermatophagoides pteronyssinus and Lolium perenne. Clin Exp Allergy. 2001;31:1007–1013. [PubMed: 11467990] 968. Ocmant A, Peignois Y, Mulier S, Hanssens L, Michils A, Schandene L. Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy. J Immunol Methods. 2007;320:40–48. [PubMed: 17275019] 969. Nopp A, Cardell LO, Johansson SG, Oman H. CD-sens: a biological measure of immunological changes stimulated by ASIT. Allergy. 2009;64:811–814. [PubMed: 19220221] 970. Nopp A, Cardell LO, Johansson SG. CD-sens can be a reliable and easy-to-use complement in the diagnosis of allergic rhinitis. Int Arch Allergy Immunol. 2013;161:87–90. [PubMed: 23257907] 971. Schmid JM, Wurtzen PA, Dahl R, Hoffmann HJ. Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy. J Allergy Clin Immunol. 2014;134:741–744.e5. [PubMed: 24934275] 972. Ozdemir SK, Guloglu D, Sin BA, Elhan AH, Ikinciogullari A, Misirligil Z. Reliability of basophil activation test using CD203c expression in diagnosis of pollen allergy. Am J Rhinol Allergy. 2011;25:e225–e231. [PubMed: 22185730] 973. Leśniak M, Dyga W, Porebski G, Czarnobilska E. [Basophil activation test—a practical approach to diagnosis of common respiratory allergy]. Przegl Lek. 2015;72:725–730. Polish. [PubMed: 27024948] 974. Lesniak M, Dyga W, Rusinek B, Mazur M, Czarnobilska E. Comparison of the basophil

Author Manuscript Author Manuscript Author Manuscript Author Manuscript

activation test versus the nasal provocation test in establishing eligibility for specific immunotherapy. Pol Arch Med Wewn. 2016;126:521–529. [PubMed: 27578221]

Int Forum Allergy Rhinol . Author manuscript; available in PMC 2020 June 10.